TOKYO (Reuters) - Japan's Otsuka Holdings <4578.T> priced its $2.4 billion initial public offering at the lower end of its range, reflecting worries the drugmaker will struggle to find a successor for ...
Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) and Otsuka Pharmaceutical Co., Ltd. (Otsuka Pharmaceutical) announce that the Paradise™ Ultrasound Renal Denervation (uRDN) system is covered ...
TOKYO (Reuters) - Japanese drugmaker Otsuka Holdings plans to sell about $2.8 billion worth of shares in December, marking the world's largest initial public offering in the pharmaceuticals sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results